Portugal Construction Industry Report 2023: Market is Expected to Post 0.8% Growth in Real Terms this Year – Sector Market Size, Trend Analysis, and Forecasts, 2018-2022 & 2023-2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Portugal Construction Market Size, Trend Analysis by Sector (Commercial, Industrial, Infrastructure, Energy and Utilities,... Read more.
Global C5ISR Market Research Report 2023-2033: How AI and Cloud Computing are Reshaping Modern Warfare – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global C5ISR Market 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The landscape... Read more.
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Farfetch Limited (FTCH) Investors and Encourages Investors to Contact the Firm Before December 19, 2023
NEW YORK–(BUSINESS WIRE)–$FTCH #classactionlawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in... Read more.
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of DermTech, Inc. (DMTK) Investors and Encourages Investors to Contact the Firm Before December 15, 2023
NEW YORK–(BUSINESS WIRE)–$DMTK #classactionlawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in... Read more.
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of CS Disco, Inc. (LAW) Investors and Encourages Investors to Contact the Firm Before November 20, 2023
NEW YORK–(BUSINESS WIRE)–$LAW #classactionlawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the... Read more.
Mevion Selected to Equip BayCare’s Proton Therapy Center in Tampa
The MEVION S250-FIT Proton Therapy System will be installed in the Fred J. Woods Radiation Therapy Center at St. Joseph’s Hospital. LITTLETON, Mass.–(BUSINESS... Read more.
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
52.5% reduction with high-dose and 47.7% reduction with low-dose combination compared to baseline, and an acceptable tolerability profile Novel investigational drug... Read more.
Chemed Corporation Declares Quarterly Dividend of 40 Cents
CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents... Read more.
Mitchell Silberberg & Knupp LLP Issues Statement on Antisemitism
LOS ANGELES–(BUSINESS WIRE)–Over the past few weeks, we have been deeply troubled to see the wave of antisemitic hate taking root on college campuses... Read more.
Cadence Bank and FHLB Dallas Celebrate Opening of Affordable Apartments at Renewal Ranch
Banks Provided $750K Subsidy to the $3.3 Million Residential Development HOUSTON, Ark.–(BUSINESS WIRE)–Representatives from Cadence Bank (NYSE: CADE)... Read more.